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Abstract Using a puri¢ed protein and bisected acceptor oligo-
saccharides, we demonstrate that N-acetylglucosaminyltransfer-
ase (GnT)-V transfers a N-acetylglucosamine residue via a
L1,6-linkage to the bisected oligosaccharides. We also kineti-
cally characterized the substrate speci¢city of GnT-V with re-
spect to the bisected oligosaccharide. Although the Km values
for the bisected acceptors were comparable to that for a non-
bisected acceptor, the Vmax values for the bisected acceptors
were much lower than that for the non-bisected acceptor. These
¢ndings suggest that the acceptor speci¢city of GnT-V is
determined by the catalytic process rather than by its binding
to the substrate. It was also found that the presence of the 2-N-
acetyl group in the bisecting monosaccharide moiety plays a
critical role in determining the catalytic e⁄ciency of the
enzyme. * 2002 Federation of European Biochemical Soci-
eties. Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
The bisecting N-acetylglucosamine (GlcNAc) moiety, cata-
lyzed by N-acetylglucosaminyltransferase (GnT)-III, is known
to be a unique structure, because asparagine-linked glycans
(N-glycans) with a bisecting GlcNAc moiety do not serve as
acceptor substrates for K-mannosidase II and GnTs-II, -IV,
and -V, and, thus, the formation of additional branching is
inhibited [1^6]. As a result, the action of GnT-III prior to
GnT-IV and -V leads to the inhibition of the biosynthesis of
multi-antennary oligosaccharides. In addition to its impor-
tance in the biosynthesis of sugar chains, the signi¢cance of
the bisecting GlcNAc has been implicated in a variety of other
biological events. The biological signi¢cance of the e¡ect of
the bisecting GlcNAc on inhibiting L1,6-branch formation has
been extensively investigated. It has been proposed that the
L1,6-branching structure produced by GnT-V might be asso-
ciated with malignant transformation and tumor metastasis
[7^11]. The overexpression of GnT-III in highly metastatic
melanoma cells led to a reduction in the number of L1,6-
branches in cell surface N-glycans, with a parallel increase
in bisected oligosaccharides, and a suppression of lung meta-
stasis of the melanoma cells [12]. Therefore, the mechanism of
how bisected oligosaccharides prevent additional branching
formation is an important issue. Nuclear magnetic resonance
(NMR) studies suggest that the addition of a bisecting
GlcNAc caused a drastic alteration in the overall conforma-
tion of the N-glycans [13,14]. Furthermore, the presence of a
bisecting GlcNAc has a signi¢cant e¡ect on conformation of
the K1,6-linked mannose (Man) moiety [15], and, therefore, it
has been believed that the prevention of L1,6-branching by the
addition of a bisecting GlcNAc is due, at least in part, to the
induction of a conformational change in the N-glycans. How-
ever, analyses of the kinetics of GnT-V toward the bisected
acceptor have not been investigated, probably due to the lim-
ited availability of the puri¢ed enzyme. A large amount of
pure GnT-V is required to produce a detectable amount of
the reaction product, when bisected oligosaccharides are used
as acceptors.
In the present study, the acceptor speci¢city of GnT-V was
kinetically characterized by using a puri¢ed recombinant en-
zyme [16] and bisected acceptor substrates [17]. Our ¢ndings
show that GnT-V binds bisected acceptors at the same level
as non-bisected acceptors but transfers a GlcNAc residue via
a L1,6-linkage at a very low level. Thus, the speci¢city of
GnT-V with respect to the acceptor oligosaccharides appears
to be critically determined not during binding with the accep-
tor oligosaccharides but during the catalytic process.
2. Materials and methods
2.1. Materials
UDP-GlcNAc and UDP-glucose (Glc) were obtained from Sigma.
The standard oligosaccharides were purchased from Takara. Glyco-
sidases were obtained from the following sources: sialidase (Arthro-
bacter ureafacies) from Nacalai Tesque; L-galactosidase (jack bean)
from Seikagaku; K-fucosidase (bovine kidney) from Sigma. Other
common chemicals were obtained from Wako Pure Chemicals.
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2.2. Preparation of puri¢ed enzyme
The C-terminal histidine-tagged recombinant GnT-V, which con-
tains the catalytic region (Tyr188^Leu741) of human GnT-V, was
completely puri¢ed as described previously [16]. Protein concentra-
tions were determined using the method described by Bradford using
bovine serum albumin as a standard [18].
2.3. Preparation of acceptor substrates
A disialyl biantennary oligosaccharide was isolated from hen’s egg
yolk, as described previously [19]. The resulting free glycan was se-
quentially digested with sialidase, L-galactosidase, and K-fucosidase,
in this order, and the resulting glycan was then labeled with 2-amino-
pyridine (PA), as reported previously [20]. This obtained PA-labeled
agalactobiantennary oligosaccharide (GnGn-bi-PA) was used as a
non-bisected acceptor. Two types of bisected acceptors were obtained
from the non-bisected acceptor via catalysis by GnT-III using UDP-
GlcNAc and UDP-Glc as donor substrates [17]. The reaction prod-
ucts were then collected and concentrated. The concentrations of these
acceptor oligosaccharides were determined by the amount of the PA
group using a known amount of GnGn-bi-PA as a standard.
2.4. GnT-V activity assay
The GnT-V activity was assayed as described previously [21]. Puri-
¢ed enzyme was incubated in 125 mM MES^NaOH (pH 6.25) con-
taining 200 mM GlcNAc, 0.5% Triton X-100 and 10 mM EDTA at
37‡C, in the presence of acceptors and UDP-GlcNAc. The reaction
was terminated by heating the mixture at 100‡C for 2 min, and the
sample was then centrifuged at 15 000 rpm for 5 min in a microfuge.
The resulting supernatant was analyzed by reversed phase high per-
formance liquid chromatography (HPLC) (Shimadzu) using a TSKgel
ODS-80TM (4.6U150, Tosoh). The solvent used was a 20 mM am-
monium acetate bu¡er (pH 4.0) containing 0.1% 1-butanol. The sub-
strate and the product were isocratically separated, and £uorescence
was detected with a £uorescence detector (RF-10AXL, Shimadzu) at
excitation and emission wavelengths of 320 nm and 400 nm, respec-
tively.
2.5. Electrospray ionization mass spectrometry (ESI-MS)
ESI-MS was carried out as described previously [16,17] using an
LCQ (Finnigan) quadrupole mass spectrometer. The PA-labeled oli-
gosaccharide was dissolved in 50% aqueous methanol and introduced
into the ion source by direct infusion at a £ow rate of 3 Wl/min using a
syringe pump interfaced with the system. ESI-MS spectra were ob-
tained using the positive ion mode. The ion spray voltage and capil-
lary voltage were 4.5 kV and 10 V, respectively, and the capillary
temperature was 200‡C. Full scan spectra were obtained in the range
of 1200^2000 of m/z values.
3. Results and discussion
A puri¢ed recombinant GnT-V was produced using a ba-
culovirus^insect cell system [16] as an enzyme source and
GnGn-bi-PA (Scheme 1) as the acceptor substrate [21]. In
order to examine the issue of whether GnT-V transfers a
GlcNAc residue to the bisected acceptors, two types of PA-
labeled oligosaccharides were employed: Gn-bisected bi-PA
and Glc-bisected bi-PA (Scheme 1). These bisected acceptors
were obtained by catalysis by GnT-III as described previously
[17]. These three acceptor substrates, GnGn-bi-PA, Gn-bi-
sected bi-PA, Glc-bisected bi-PA, were eluted at 13 min, 26
min, and 7.5 min, respectively, on a reversed phase HPLC,
under the conditions described in Section 2 (Fig. 1A). When
puri¢ed GnT-V was incubated with GnGn-bi-PA, Gn-bisected
bi-PA, or Glc-bisected bi-PA (10 WM each) in the presence of
4 mM UDP-GlcNAc, the peaks corresponding to the reaction
products were detected at 8.6 min, 18 min, and 6.0 min, re-
spectively (Fig. 1B^D). Thus, by use of a high concentration
of GnT-V (40 ng/Wl), it is indicated that GnT-V is also able to
transfer GlcNAc to these bisected acceptors, even if to a much
lesser extent.
To con¢rm the transfer of a GlcNAc to the bisected oligo-
saccharides by GnT-V, the reaction products were collected
and analyzed by ESI-MS. As shown in Fig. 2A, the m/z value
of (M+H)þ of the reaction product using GnGn-bi-PA as a
substrate was 1598.5, corresponding to that of triP-PA
(Scheme 1). Similarly, the m/z values of the material in the
product peaks using Gn-bisected bi-PA and Glc-bisected bi-
PA as a substrates were 1801.5 (Fig. 2B) and 1760.5 (Fig. 2C),
corresponding to those of Gn-bisected triP-PA and Glc-bi-
sected triP-PA, respectively. These results verify that GnT-V
is capable of transferring a GlcNAc residue to bisected accep-
tors.
Scheme 1. The reactions catalyzed by GnT-V. The transfer reaction of a L1,6-branched GlcNAc residue to various acceptor oligosaccharides.
R represents 4GlcNAcL1-4GlcNAc.
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The elucidation of a kinetic factor associated with the trans-
fer rates would be important for understanding the mecha-
nism underlying the substrate speci¢city of GnT-V. To ad-
dress this issue, kinetic analyses for bisected acceptors as
well as a non-bisected acceptor were carried out. When
GnT-V activities were assayed using various concentrations
of UDP-GlcNAc in the presence of a ¢xed concentration
(10 WM) of various acceptors, it was found that the reactions
followed typical Michaelis^Menten type kinetics (Fig. 3A).
The apparent Km values for the donor were 10 mM and 7.4
mM in the case where Gn-bisected bi-PA and Glc-bisected bi-
PA were used as acceptors, respectively, which are slightly
higher than that for GnGn-bi-PA (6.0 mM). This result in-
dicates that the presence of a bisecting monosaccharide moi-
ety in acceptors has no signi¢cant e¡ect on the binding to the
donor.
In order to determine the Km values for acceptors, activities
were next assayed using various concentrations of acceptors in
the presence of 80 mM UDP-GlcNAc (Fig. 3B). Because this
donor concentration is su⁄ciently high as compared to the
Km values, kinetic parameters close to the true values would
be obtained for the acceptors. With respect to GnGn-bi-PA,
the values for Km (180 WM) and Vmax (17 Wmol/h/mg) are
nearly the same as those reported in our previous study
[16]. As summarized in Table 1, it was found that the Km
values for the three acceptors examined in this study were
essentially equal. An earlier study showed that the Km value
for a trisaccharide acceptor is similar to the Ki value for its
6P-deoxy analog [22], thus permitting an assumption that Km
Fig. 1. Detection of GnT-V activities using various bisected oligo-
saccharides. The puri¢ed GnT-V was incubated with 10 WM of
GnGn-bi-PA (B), Gn-bisected bi-PA (C), and Glc-bisected bi-PA
(D) in the presence of 4 mM UDP-GlcNAc. The elution times for
the non-reacted acceptors are shown in A. No substrate remained in
the case of GnGn-bi-PA (*) because of its much faster reaction
rate.
Table 1
Kinetic parameters for the transfer reactions catalyzed by puri¢ed GnT-V
Acceptor substrate Acceptor Donor
Vmax Km Vmax/Km app. Km
(nmol/h/mg) (%) (WM) (%) (mM)
GnGn-bi-PA 17000 (100) 180 94 (100) 6.0
Gn-bisected bi-PA 0.76 (0.0045) 140 0.0054 (0.0057) 10
Glc-bisected bi-PA 4.32 (0.025) 82 0.054 (0.056) 7.4
Fig. 2. ESI-MS analysis of the reaction products by GnT-V. MS
spectra of the reaction products from Gn-bisected bi-PA (B) and
Glc-bisected bi-PA (C) are shown with that of the product from
GnGn-bi-PA (A). Detailed conditions for the analysis are described
in Section 2.
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is equal to Kd. Therefore, the results suggest that the GnT-
V:donor complex, which is initially formed [23], binds to bi-
sected acceptors comparably as to a non-bisected acceptor.
This was an unexpected result because it has been thought
that the inhibitory e¡ect of the bisecting GlcNAc on the ac-
tion of GnT-V is due to the induction of conformational
change in the trisaccharide moiety which is recognized by
the enzyme L-D-GlcNAc-(1-2)-K-D-Man-(1-6)-L-D-GlcNAc-L-
OR, particularly K1,6-linked Man residue, as suggested by
several reports including NMR studies [13^15,24,25].
On the other hand, the Vmax values for Gn-bisected and
Glc-bisected acceptors were 22 000 and 3900 times lower, re-
spectively, than that for the non-bisected acceptor. Assuming
that the binding mode for the GlcNAc- and Glc-bisected ac-
ceptors is the same, it seems likely that the presence of the
bisecting monosaccharides more signi¢cantly a¡ects the cata-
Fig. 3. Kinetic analyses of GnT-V reactions using non-bisected and bisected acceptor oligosaccharides. A: GnT-V activity was measured with
various concentrations of UDP-GlcNAc in the presence of a ¢xed concentration (10 WM) of acceptors. The results are shown in the form of
double reciprocal plots. The plots obtained using GnGn-bi-PA as an acceptor (left panel) are separated from the other two plots (right panel),
because of the much faster reaction rate. B: GnT-V activity was measured with various concentrations of acceptors in the presence of a ¢xed
concentration (80 mM) of UDP-GlcNAc. The results are shown in the form of double reciprocal plots. The plots obtained using GnGn-bi-PA
as an acceptor (left panel) are separated from the other two plots (right panel), because of its much faster reaction rate.
Fig. 4. Biosynthetic pathways of bisected triP-antennary oligosaccharide. The pathways from biantennary oligosaccharide to bisected triP-antenn-
ary oligosaccharide are shown. The double line indicates the step that is inhibited by the presence of the bisecting GlcNAc. R represents
4GlcNAcL1-4GlcNAcL-Asn (in polypeptide).
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lytic step than the binding step. On the basis of the catalytic
e⁄ciency (Vmax/Km for the acceptor), the speci¢city of GnT-V
with respect to the non-bisected acceptor was estimated to be
at least 17 000 and 1700 times higher than that for Gn-bi-
sected and Glc-bisected acceptors, respectively. This indicates
that the speci¢city for Glc-bisected bi-PA was approximately
10 times higher, compared to the Gn-bisected bi-PA. Since the
di¡erence in the kinetic parameters between these two bisected
acceptors can only be attributed to the e¡ect of the presence
of a 2-N-acetyl group on the bisecting monosaccharide moi-
eties, not only the presence of a bisecting monosaccharide per
se but the presence of the 2-N-acetyl group in the monosac-
charide portion is also a signi¢cant factor that a¡ects cataly-
sis. In addition to possible steric hindrance, this could be
rationalized, for example, by the formation of a hydrogen
bond which is unfavorable for the catalysis.
The oligosaccharide moieties on glycoconjugates are as-
sembled via the sequential action of various glycosyltransfer-
ases in the Golgi apparatus [26]. Therefore, not only the levels
of expression and activities of the glycosyltransferases but the
speci¢cities toward the acceptor oligosaccharides are also crit-
ical determinants of the ultimate oligosaccharide structures.
Because GnT-III and GnT-V share a common substrate, aga-
lacto-biantennary oligosaccharide, GnT-V competes with
GnT-III for a substrate (Fig. 4). As demonstrated in the
present study, the Vmax/Km value for the Gn-bisected oligo-
saccharide was more than 17 000 times lower than that for the
non-bisected oligosaccharide, thus, once the bisecting-GlcNAc
is added the oligosaccharides would not function as an accep-
tor for GnT-V, in vivo. Namely, the prior action of GnT-V to
GnT-III is necessary to produce the bisected triP-antennary
oligosaccharide (Fig. 4). Thus, the requirement of the sequen-
tial and ordered actions of glycosyltransferases is caused by
acceptor speci¢city, and the ‘catalysis-dependent speci¢city’
presented in this study may be convenient for regulating the
complex biosynthesis of oligosaccharide structures, in which a
considerable number of glycosyltransferases are concerned.
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